Comparative protective effect of the inhaled β2-agonist salbutamol (albuterol) on bronchoconstriction provoked by histamine, methacholine, and adenosine 5′-monophosphate in asthma
Open Access
- 1 April 1990
- journal article
- research article
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 85 (4) , 755-762
- https://doi.org/10.1016/0091-6749(90)90195-a
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Dose related effects of salbutamol and ipratropium bromide on airway calibre and reactivity in subjects with asthma.Thorax, 1988
- Use of bronchial provocation with histamine to compare the pharmacodynamics of inhaled albuterol and metaproterenol in patients with asthmaJournal of Allergy and Clinical Immunology, 1987
- Relationship between Mediator Release from Human Lung Mast Cells in vitro and in vivoInternational Archives of Allergy and Immunology, 1985
- Effect of aerosol fenoterol on the severity of bronchial hyperreactivity in patients with asthma.Thorax, 1983
- Exercise-induced release of histamine and neutrophil chemotactic factor in atopic asthmaticsJournal of Allergy and Clinical Immunology, 1982
- A calcium antagonist, nifedipine, modifies exercise-induced asthma.Thorax, 1981
- The effect of ipratropium and fenoterol on methacholine- and histamine-induced bronchoconstrictionRespiratory Medicine, 1981
- Arterial plasma histamine levels at rest, and during and after exercise in patients with asthma: effects of terbutaline aerosol.Thorax, 1981
- Histamine release in exercise-induced asthma.BMJ, 1978
- Protective effect of drugs on histamine-induced asthma.Thorax, 1977